- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 26
Second-Generation Antidepressants for Treating Adult Depression—An Update
Outline of Material
Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development
Background: Treatment for Depression
Background: Antidepressant Medications
Comparative Effectiveness Review on Second-Generation Antidepressants for Adults With Depression
Second-Generation Antidepressants Included in the 2011 Updated Review
Outcomes of Interest in Studies on Second-Generation Antidepressants for Depression
Keywords: outcomes | second-generation antidepressants | response | remission | adverse effects
Overall Comparative Effectiveness of Second-Generation Antidepressants for Treating Major Depressive Disorder
Overall Comparative Effectiveness of Second-Generation Antidepressants for Treating Adults With MDD
Keywords: efficacy | effectiveness | onset of action | elderly | adverse events
IImmediate-Release Versus Extended-Release Formulations of Second-Generation Antidepressants for Adults With MDD
Adherence and Persistence in Second-Generation Antidepressants for Adults With MDD
Your slide tray is being processed.